Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Romosozumab on Bone Health in Women With Spinal Cord Injury and Osteoporosis

NCT04708886 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04708886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Romosozumab on Bone Health in Women With Spinal Cord Injury and Osteoporosis
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2021
Completion date
June 10, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss, chronic spinal paralysis, osteopenia, osteoporosis, osteoporosis, spinal cord injuries